1-10 of 10
Lara H. Böhmer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunosuppressed Tumor Microenvironment in MYC -Rearranged High-Grade B-Cell Lymphomas Compared to Diffuse Large B-Cell Lymphomas, Not Otherwise Specified

A. De Jonge, Troy Noordenbos, Ruben A.L. De Groen, Fleur A. De Groot, Lorraine M. De Haan-Treurniet, Patty M. Jansen, Liping Fu, Koen de Heer, Clara Klerk, Yorick Sandberg, Rob Fijnheer, Pim Mutsaers, Aart Beeker, Lara H. Böhmer, Steven Wang, Leonie Strobbe, Rinske Boersma, Margriet Oosterveld, Harry R. Koene, Noel De Miranda, Anke Van Den Berg, Marcel Nijland, Margaretha G.M. Roemer, Tuna Mutis, Martine E.D. Chamuleau, Joost S.P. Vermaat
Journal: Blood
Blood (2024) 144 (Supplement 1): 4380.
https://doi.org/10.1182/blood-2024-205968
Published: 2024
Journal Articles

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

A.Vera de Jonge, Marie José Kersten, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara Klerk, Yorick Sandberg, Rozemarijn S Van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Roel JW van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S.P Vermaat, Otto Visser, Josée M. Zijlstra, Henk Hofwegen, Helma G.J.M. Zanders, Liping P. Fu, Daphne De Jong, Marcel Nijland, Martine E.D. Chamuleau
Journal: Blood
Blood (2023) 142 (Supplement 1): 3090.
https://doi.org/10.1182/blood-2023-181707
Published: 2023
Journal Articles

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Ruben A.L. De Groen, Fleur A De Groot, Lorraine M. De Haan, Tom van Wezel, Troy Noordenbos, Stefan Boehringer, Ronald Van Eijk, Richard Raghoo, Dina Ruano, Aniko Sijs-Szabo, Liane te Boome, Valeska Terpstra, Henriette Levenga, Aline Nicolae, Ward Posthuma, Isabelle Focke-Snieders, Lizan Hardi, Wietske den Hartog, Lara H. Böhmer, Anke Van Den Berg, Pim Mutseaers, Marjolein W.M. Van Der Poel, Myrurgia Abdul Hamid, F.J. Sherida H. Woei-a-Jin, Ann Janssens, Thomas Tousseyn, Judith Bovée, Hendrik Veelken, Steven T Pals, Arjan Diepstra, Marcel Nijland, Marie José Kersten, Patty M. Jansen, Arjen Cleven, Joost S.P. Vermaat
Journal: Blood
Blood (2022) 140 (Supplement 1): 3534–3536.
https://doi.org/10.1182/blood-2022-159036
Published: 2022
Journal Articles

Lenalidomide-Rituximab or Lenalidomide-Rituximab-Bendamustine in Patients with Relapsed/Refractory Follicular Lymphoma: Priimary Analysis of the Randomized Phase II HOVON110/Rebel Trial

Marie José Kersten, Martin Dreyling, Kim M. Linton, Dana Chitu, Sanne Tonino, Marcel Kap, Roberto D Liu, Martine E.D. Chamuleau, Hein P.J. Visser, Eva De Jongh, Erik WAF Marijt, Maria B.L. Leijs, Yavuz M. Bilgin, Jan Dürig, Pamela McKay, Tjeerd J.F. Snijders, Andrew Pettitt, Monique C. Minnema, Gabriele Prange-Krex, Maria Cuijpers, Lara H. Böhmer, Lidwine W. Tick, Axel Florschütz, Matthijs Silbermann, Rob Fijnheer, Aart Beeker, Nelleke Tolboom, Cristina Mitea, Anne IJ Arens, Gerben JC Zwezerijnen, Wolfram Klapper, Sarah E. Coupland, Daphne de Jong, Jeanette K. Doorduijn, Josée M. Zijlstra
Journal: Blood
Blood (2022) 140 (Supplement 1): 2283–2285.
https://doi.org/10.1182/blood-2022-156085
Published: 2022
Journal Articles

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Fleur A De Groot, Jeanette K. Doorduijn, Mirian Brink, Ruben A.L. De Groen, Lorraine M. De Haan, Troy Noordenbos, Aniko Sijs-Szabo, King Hong Lam, Arjan Diepstra, Liane te Boome, Valeska Terpstra, Lara H. Böhmer, Josée M. Zijlstra, Lianne Koens, Marc Durian, Mirjam A. Oudshoorn, Hendrik Veelken, Marjolein W.M. Van Der Poel, Myrurgia Abdul Hamid, Wendy B.C. Stevens, J L.M van Rooij, Rimke Oostvogels, Karen J. Neelis, Michiel van den Brand, F.J. Sherida H. Woei-a-Jin, Thomas Tousseyn, Daan Dierickx, Patty M. Jansen, Marie Jose Kersten, Jacoline Bromberg, Marcel Nijland, Joost S.P. Vermaat
Journal: Blood
Blood (2022) 140 (Supplement 1): 369–371.
https://doi.org/10.1182/blood-2022-163244
Published: 2022
Journal Articles

Immune Profiling of Double and Triple Hit High Grade B Cell Lymphoma Patients Treated with DA-EPOCH Reveals Activation of T Cells and Reduced T Cell Exhaustion

A.Vera de Jonge, Carolien Duetz, Wassilis S.C. Bruins, Erik D. van Werkhoven, Marcel Nijland, Marjolein W.M. Van Der Poel, Koen de Heer, Clara P.W. Klerk, Yorick Sandberg, Rob Fijnheer, Pim Mutseaers, Djamila E. Issa, Lara H. Böhmer, Roel J.W. Van Kampen, Otto J. Visser, Daphne de Jong, Josée M. Zijlstra, Tuna Mutis, Martine E.D. Chamuleau
Journal: Blood
Blood (2022) 140 (Supplement 1): 9298–9299.
https://doi.org/10.1182/blood-2022-163068
Published: 2022
Journal Articles

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

Clinical Trials & Observations
Mirian Brink, Frederik O. Meeuwes, Marjolein W. M. van der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G. N. J. Mutsaers, Lara H. Böhmer, F. J. Sherida H. Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Wouter Plattel, Gerwin A. Huls, Joost S. P. Vermaat, Marcel Nijland
Journal: Blood
Blood (2022) 140 (9): 1009–1019.
https://doi.org/10.1182/blood.2021015114
Published: 2022
Includes: Supplemental data
Journal Articles

First-Line Treatment and Survival of Stage I(E) Peripheral T-Cell Lymphoma in the Netherlands; A Nationwide Population-Based Cohort Study

Frederik O. Meeuwes, Mirian Brink, Marjolein W.M. Van Der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G.N.J. Mutsaers, Lara H. Böhmer, F.J. Sherida H. Woei-a-Jin, Otto J. Visser, Rimke Oostvogels, Patty M. Jansen, Karen J. Neelis, Anne P.G. Crijns, Laurien A. Daniëls, Joost S.P. Vermaat, Gerwin A. Huls, Marcel Nijland
Journal: Blood
Blood (2021) 138 (Supplement 1): 1381.
https://doi.org/10.1182/blood-2021-148038
Published: 2021
Journal Articles

Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial

Marie José Kersten, MD PhD, Monique C. Minnema, Josephine M. Vos, MD PhD, Kazem Nasserinejad, Marcel Kap, BSc, Eftathios Kastritis, Maria Gavriatopoulou, MD, Martine E.D. Chamuleau, Dries Deeren, MD PhD, Lidwine Winnifred Tick, MD PhD, Jeanette K. Doorduijn, MD PhD, Fritz Offner, MD, Lara H Bohmer, MD, Karima Amaador, MD, Roberto D Liu, BSc, Steven T Pals, MD PhD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 344.
https://doi.org/10.1182/blood-2019-122365
Published: 2019
Journal Articles

Rituximab-Pecc Induction Followed By 90 y-Ibritumomab Tiuxetan Consolidation in Relapsed or Refractory DLBCL Patients Who Are Not Eligible for or Have Failed ASCT: Results from a Phase II HOVON Study

Pieternella J Lugtenburg, MD PhD, Josée M Zijlstra, MD, Jeanette K Doorduijn, MD PhD, Lara H Böhmer, MD, Marinus van Marwijk Kooy, MD PhD, Mels Hoogendoorn, MD PhD, Henriette W Berenschot, MD, Aart Beeker, MD, Fransje Valster, MD, Harry C. Schouten, MD PhD, Marleen Luten, MSc, Henk Hofwegen, Dana A Chitu, PhD, Rolf E Brouwer, MD PhD, Gustaaf W van Imhoff, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2707.
https://doi.org/10.1182/blood.V126.23.2707.2707
Published: 2015